Ann: NSB - Breakthrough results from Spinal Cord Injury Model, page-3

This is HUGE.

EmtinB demonstrated the largest ever improvement in neurite growth and increased number of active connections between nerve cells. Treatment with EmtinB produced longest axon ever sampled by this disease model. An increase in the length of axon is a measure of nerve’s cell ability to regenerate
▪ EmtinB stimulated nerve regeneration exceeding 300% compared to control and double that of Copaxon®, the leading marketed drug for Multiple Sclerosis with peak annual sales of $4 billion dollars
▪ Results clearly demonstrate significant promise of Emtins’ neuroprotective effects in multiple neurodegenerative diseases, such as Alzheimer’s, Multiple Sclerosis, Parkinson’s, etc.

Market Cap $10M with $5M+ cash